ALINS.PA · Intrasense SA

-

Please sign in to comment on ALINS.PA

1 Comment

Admin

4 years, 4 months ago

Intrasense SA is currently in a long term downtrend where the price is trading 36.3% below its 200 day moving average.

From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.

Intrasense SA's total revenue sank by 0.0% to $1M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $-16K since the same quarter in the previous year.

Based on the above factors, Intrasense SA gets an overall score of 1/5.

Exchange	PA
CurrencyCode	EUR
ISIN	FR0011179886
Sector	Healthcare
Industry	Health Information Services

Market Cap	15M
PE Ratio	None
Target Price	0.2
Beta	-0.02
Dividend Yield	None

ABOUT

Intrasense SA

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, a, oncological imaging platform that automates the identification and measurement of lesions. The company was incorporated in 2004 and is headquartered in Montpellier, France.

ALINS.PA · Intrasense SA

-

Intrasense SA

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Intrasense SA using a moving average strategy